Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.71
-6.5%
$0.89
$0.54
$4.00
$39.42M-0.861.18 million shs463,028 shs
Biocorrx Inc. stock logo
BICX
Biocorrx
$0.40
+21.2%
$0.37
$0.20
$1.28
$11.80M0.166,758 shs4,900 shs
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$0.04
$0.05
$0.75
$1.65
$1.06M-0.88708,132 shs10,044 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
0.00%+0.24%-13.54%-33.95%-50.51%
Biocorrx Inc. stock logo
BICX
Biocorrx
0.00%-13.16%-17.50%-17.50%-2.94%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00%0.00%-13.04%-28.83%-20.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.71
-6.5%
$0.89
$0.54
$4.00
$39.42M-0.861.18 million shs463,028 shs
Biocorrx Inc. stock logo
BICX
Biocorrx
$0.40
+21.2%
$0.37
$0.20
$1.28
$11.80M0.166,758 shs4,900 shs
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$0.04
$0.05
$0.75
$1.65
$1.06M-0.88708,132 shs10,044 shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
0.00%+0.24%-13.54%-33.95%-50.51%
Biocorrx Inc. stock logo
BICX
Biocorrx
0.00%-13.16%-17.50%-17.50%-2.94%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00%0.00%-13.04%-28.83%-20.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HeartBeam, Inc. stock logo
BEAT
HeartBeam
2.63
Moderate Buy$4.33510.24% Upside
Biocorrx Inc. stock logo
BICX
Biocorrx
2.00
HoldN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BICX, IMAC, and BEAT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Lower Price TargetBuy$5.50 ➝ $2.50
5/15/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Lower Price TargetSpeculative Buy$8.00 ➝ $5.00
4/20/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
DowngradeBuyHold
3/31/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Initiated CoverageBuy$4.00
3/30/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
UpgradeStrong-Buy
3/27/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Initiated CoverageBuy$5.00
(Data available from 6/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/A$0.06 per shareN/A
Biocorrx Inc. stock logo
BICX
Biocorrx
$800K14.75N/AN/A($0.47) per share-0.85
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$15.22M0.07N/AN/A$0.69 per share0.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$21.01M-$0.56N/AN/AN/AN/A-1,034.04%-434.40%8/12/2026 (Estimated)
Biocorrx Inc. stock logo
BICX
Biocorrx
-$3.44M-$0.16N/AN/AN/AN/AN/A-73.40%8/17/2026 (Estimated)
IMAC Holdings, Inc. stock logo
IMAC
IMAC
-$10.54M-$0.27N/AN/AN/A-75.40%-52.17%-34.51%N/A

Latest BICX, IMAC, and BEAT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Biocorrx Inc. stock logo
BICX
Biocorrx
-$0.06-$0.03+$0.03-$0.03$0.22 million$0.22 million
5/13/2026Q1 2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$0.14-$0.12+$0.02-$0.12$0.15 millionN/A
3/31/2026Q4 2025
Biocorrx Inc. stock logo
BICX
Biocorrx
-$0.06$0.05+$0.11$0.05$0.22 million($0.15) million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/AN/A
Biocorrx Inc. stock logo
BICX
Biocorrx
N/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/A
0.74
0.70
Biocorrx Inc. stock logo
BICX
Biocorrx
N/A
0.12
0.10
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.01
1.27
1.27

Institutional Ownership

CompanyInstitutional Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
7.77%
Biocorrx Inc. stock logo
BICX
Biocorrx
N/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
24.27%

Insider Ownership

CompanyInsider Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
18.04%
Biocorrx Inc. stock logo
BICX
Biocorrx
21.40%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
HeartBeam, Inc. stock logo
BEAT
HeartBeam
1,70055.51 million45.49 millionNot Optionable
Biocorrx Inc. stock logo
BICX
Biocorrx
329.50 million23.19 millionNot Optionable
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10626.49 million23.84 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HeartBeam stock logo

HeartBeam NASDAQ:BEAT

$0.71 -0.05 (-6.52%)
Closing price 04:00 PM Eastern
Extended Trading
$0.72 +0.01 (+0.83%)
As of 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Biocorrx stock logo

Biocorrx OTCMKTS:BICX

$0.40 +0.07 (+21.21%)
As of 09:31 AM Eastern

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

IMAC stock logo

IMAC NASDAQ:IMAC

$0.04 0.00 (0.00%)
As of 06/18/2026

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.